{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:47:29Z","timestamp":1790264849704,"version":"4.1.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1001\/jamainternmed.2019.0981","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T15:01:07Z","timestamp":1561993267000},"page":"1034","source":"Crossref","is-referenced-by-count":162,"title":["Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism"],"prefix":"10.1001","volume":"179","author":[{"given":"Cari M.","family":"Kitahara","sequence":"first","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Berrington de Gonzalez","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Bouville","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Brill","sequence":"additional","affiliation":[{"name":"Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Doody","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunstana R.","family":"Melo","sequence":"additional","affiliation":[{"name":"Melohill Technology LLC, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Simon","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Sosa","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tulchinsky","sequence":"additional","affiliation":[{"name":"Department of Radiology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphn\u00e9e","family":"Villoing","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale L.","family":"Preston","sequence":"additional","affiliation":[{"name":"Hirosoft International, Eureka, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"ioi190030r1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"4","key":"ioi190030r2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.280.4.347","article-title":"Cancer mortality following treatment for adult hyperthyroidism.","volume":"280","author":"Ron","year":"1998","journal-title":"JAMA"},{"issue":"12","key":"ioi190030r3","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease.","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ioi190030r4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves\u2019 disease.","volume":"84","author":"Bartalena","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"ioi190030r5","doi-asserted-by":"publisher","first-page":"djv314","DOI":"10.1093\/jnci\/djv314","article-title":"Use of radioactive iodine for thyroid cancer and risk of second primary malignancy: a nationwide population-based study.","volume":"108","author":"Teng","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"ioi190030r6","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1038\/s41375-018-0149-2","article-title":"Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.","volume":"32","author":"Teepen","year":"2018","journal-title":"Leukemia"},{"issue":"18","key":"ioi190030r7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1200\/JCO.2017.75.0232","article-title":"Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer.","volume":"36","author":"Molenaar","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"ioi190030r8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/thy.2011.0406","article-title":"The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.","volume":"23","author":"Kim","year":"2013","journal-title":"Thyroid"},{"key":"ioi190030r9","article-title":"A systematic review and meta-analysis of subsequent malignant neoplasm risk after radioactive iodine treatment of thyroid cancer [published online November 27, 2018].","author":"Yu","journal-title":"Thyroid"},{"issue":"15","key":"ioi190030r10","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/83.15.1072","article-title":"Cancer risk after iodine-131 therapy for hyperthyroidism.","volume":"83","author":"Holm","year":"1991","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"ioi190030r11","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Increased cancer incidence after radioiodine treatment for hyperthyroidism.","volume":"109","author":"Metso","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"ioi190030r12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Cancer mortality after iodine-131 therapy for hyperthyroidism.","volume":"50","author":"Hall","year":"1992","journal-title":"Int J Cancer"},{"issue":"9170","key":"ioi190030r13","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/S0140-6736(98)12295-X","article-title":"Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.","volume":"353","author":"Franklyn","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"ioi190030r14","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1210\/jc.2015-1874","article-title":"Cancer incidence and mortality in patients treated either with RAI or thyroidectomy for hyperthyroidism.","volume":"100","author":"Ry\u00f6di","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ioi190030r15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1667\/RR14160.1","article-title":"Organ dose estimates for hyperthyroid patients treated with (131)I: an update of the thyrotoxicosis follow-up study.","volume":"184","author":"Melo","year":"2015","journal-title":"Radiat Res"},{"issue":"12","key":"ioi190030r16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jama.1968.03140380059014","article-title":"Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study.","volume":"205","author":"Saenger","year":"1968","journal-title":"JAMA"},{"issue":"6","key":"ioi190030r17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1210\/jcem-38-6-976","article-title":"Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.","volume":"38","author":"Dobyns","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ioi190030r18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.icrp.2008.10.001","article-title":"ICRP Publication 107. Nuclear decay data for dosimetric calculations.","volume":"38","author":"Eckerman","year":"2008","journal-title":"Ann ICRP"},{"issue":"1","key":"ioi190030r19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/rpd\/ncv016","article-title":"S values for 131I based on the ICRP adult voxel phantoms.","volume":"168","author":"Lamart","year":"2016","journal-title":"Radiat Prot Dosimetry"},{"issue":"2","key":"ioi190030r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.icrp.2009.07.001","article-title":"ICRP Publication 110. Realistic reference phantoms: an ICRP\/ICRU joint effort. A report of adult reference computational phantoms.","volume":"39","author":"Menzel","year":"2009","journal-title":"Ann ICRP"},{"issue":"3","key":"ioi190030r23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00004032-199209000-00001","article-title":"Definition and estimation of lifetime detriment from radiation exposures: principles and methods.","volume":"63","author":"Thomas","year":"1992","journal-title":"Health Phys"},{"key":"ioi190030r24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/CLEP","article-title":"Control of confounding in the analysis phase: an overview for clinicians.","volume":"9","author":"Kahlert","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"8","key":"ioi190030r25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/thy.2017.0063","article-title":"Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women.","volume":"27","author":"Journy","year":"2017","journal-title":"Thyroid"},{"issue":"4","key":"ioi190030r26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study.","volume":"174","author":"S\u00f8gaard","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"17","key":"ioi190030r27","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by indication in clinical research.","volume":"316","author":"Kyriacou","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"ioi190030r28","first-page":"335","article-title":"Confounding by indication.","volume":"7","author":"Walker","year":"1996","journal-title":"Epidemiology"},{"issue":"3","key":"ioi190030r29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Breast cancer in Belarus and Ukraine after the Chernobyl accident.","volume":"119","author":"Pukkala","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"ioi190030r30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998.","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat Res"},{"issue":"9","key":"ioi190030r31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/bjc.2016.292","article-title":"Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983-2008.","volume":"115","author":"Preston","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"ioi190030r32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1667\/0033-7587(2002)158[0220:REOBCR]2.0.CO;2","article-title":"Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.","volume":"158","author":"Preston","year":"2002","journal-title":"Radiat Res"},{"issue":"1","key":"ioi190030r33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1667\/RR14023.1","article-title":"Solid cancer incidence in the Techa River Incidence cohort: 1956-2007.","volume":"184","author":"Davis","year":"2015","journal-title":"Radiat Res"},{"issue":"2","key":"ioi190030r34","doi-asserted-by":"publisher","first-page":"e0117784","DOI":"10.1371\/journal.pone.0117784","article-title":"Radiation effects on mortality from solid cancers other than lung, liver, and bone cancer in the Mayak worker cohort: 1948-2008.","volume":"10","author":"Sokolnikov","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"ioi190030r35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1667\/RR14213.1","article-title":"Thyroid cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies.","volume":"185","author":"Veiga","year":"2016","journal-title":"Radiat Res"},{"issue":"7","key":"ioi190030r36","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S2352-3026(15)00094-0","article-title":"Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study.","volume":"2","author":"Leuraud","year":"2015","journal-title":"Lancet Haematol"},{"issue":"8","key":"ioi190030r37","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1016\/S2352-3026(18)30092-9","article-title":"Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies.","volume":"5","author":"Little","year":"2018","journal-title":"Lancet Haematol"},{"issue":"23","key":"ioi190030r38","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of Graves disease: a review.","volume":"314","author":"Burch","year":"2015","journal-title":"JAMA"},{"issue":"7592","key":"ioi190030r39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/bmj.39114.670150.BE","article-title":"Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.","volume":"334","author":"Walter","year":"2007","journal-title":"BMJ"},{"key":"ioi190030r21","unstructured":"PrestonDL, LubinJH, PierceDA, McConneyME, ShilnikovaNS. EPICURE user manual and command summary. http:\/\/epicurehelp.risksciences.com. Accessed February 20, 2018."},{"key":"ioi190030r22","unstructured":"Surveillance, Epidemiology, and End Results Program. US mortality data, 1969-2015. National Cancer Institute. https:\/\/seer.cancer.gov\/mortality\/. Accessed February 20, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/article-pdf\/179\/8\/1034\/17754756\/jamainternal_kitahara_2019_oi_190030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T16:25:05Z","timestamp":1565022305000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2737319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.0981","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}